What do global trade disputes have to do with your Medicare Advantage bid? More than you might think.You’ve probably heard about tariffs in the news—but did you know they could shake up Medicare Advantage strategies?In this episode, Jenn breaks down how the latest round of tariffs on imports from China, Mexico, and Canada might impact your 2026 CMS bid, pharmacy costs, and—yep—even your Star Ratings. Add in the Inflation Reduction Act and the new Part D redesign, and things start to get spicy real fast.If you’re in the weeds with benefit design, predicting costs and impact, or member experience strategy, this 15-minute download is for you. Jenn walks through the real-world impacts, why generics could get more expensive, and what members might notice in their plans next year.

Ver todos los episodios